Sanofi Covid Vaccine
- All
- News
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Sanofi And GSK Launch Final Testing Phase Of New Covid Vaccine
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
Sanofi, GSK Covid Vaccine To Be Ready Only At The End Of 2021
France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Sanofi And GSK Launch Final Testing Phase Of New Covid Vaccine
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
Sanofi, GSK Covid Vaccine To Be Ready Only At The End Of 2021
France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.
